Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMERICAN INTERNATIONAL HOLDINGS CORP.AMIH · Entity 114347 | Director | May 06, 2022 | April 13, 2023 |
| MANGOCEUTICALS, INC.MGRX · Entity 8073 | Director · Chief Executive Officer · 10% owner | September 30, 2025 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMERICAN INTERNATIONAL HOLDINGS CORP.
Report date May 06, 2022 · Filed April 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Preferred StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-06 transaction · row 1
1 source rowRow 1 · 2022-05-06 · Other · Disposed 1 · Balance 0 F1: Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3. |
| Common StockSEC Table I · non-derivative | IndirectHeld by Cohen Enterprises, Inc | 6,458,333 |
Reported balance
After 2022-12-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-12-31 · Grant · Acquired 6,000,000 · Balance 6,458,333 F1: Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3. |
| Series A Preferred StockSEC Table II · derivative / convertible security | Direct | 1,000,000 |
Reported balance
After 2022-05-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-06 · Other · Acquired 1,000,000 · Balance 1,000,000 F3: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F2: On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the "Restated Designation"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security. F4: Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer. F5: The Series A Preferred Stock has no expiration date. F6: No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer. |
| Series A Preferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2023-02-15 · Other · Disposed 1,000,000 · Balance 0 F3: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F7: On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the "Exchange Agreement"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000. F4: Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer. F5: The Series A Preferred Stock has no expiration date. F6: No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer. |
Filing footnotes · ownership attribution and instrument terms
F1: Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3.
F2: On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the "Restated Designation"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security.
F3: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding.
F4: Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer.
F5: The Series A Preferred Stock has no expiration date.
F6: No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer.
F7: On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the "Exchange Agreement"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000.
MANGOCEUTICALS, INC.
Report date September 30, 2025 · Filed October 06, 2026
Jointly reported with Tiger Cub Trust
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-09-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-30 · Gift · Disposed 500,000 · Balance 0 F1: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2: Represents Mr. Cohen's direct ownership of the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 1,305,000 |
Reported balance
After 2025-09-30 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2025-09-30 · Gift · Acquired 500,000 · Balance 1,305,000 F1: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | Direct | 2,000,000 |
Reported balance
After 2026-07-28 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2026-07-28 · Grant · Acquired 2,000,000 · Balance 2,000,000 F4: Issuable to Mr. Cohen as a bonus in lieu of a change of control payment which would have otherwise been due under this Employment Agreement. F2: Represents Mr. Cohen's direct ownership of the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-08-11 transaction · row 4
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 4 · 2026-08-11 · Gift · Disposed 2,000,000 · Balance 0 F1: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2: Represents Mr. Cohen's direct ownership of the Issuer. |
| Common StockSEC Table I · non-derivative | Direct | 3,305,000 |
Reported balance
After 2026-08-11 transaction · row 5
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 5 · 2026-08-11 · Gift · Acquired 2,000,000 · Balance 3,305,000 F1: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. |
| Convertible Promissory NoteSEC Table II · derivative / convertible security · Conversion / exercise price $1.79 · Expires 2026-05-02 | Direct | Not disclosed |
Reported balance
After 2025-12-19 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2025-12-19 · Other · Disposed Not disclosed · Balance Not disclosed F5: On December 19, 2025, the Convertible Promissory Note was paid in full. F6: Represents the maturity date of the Convertible Promissory Note. F3: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities.
F2: Represents Mr. Cohen's direct ownership of the Issuer.
F3: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.
F4: Issuable to Mr. Cohen as a bonus in lieu of a change of control payment which would have otherwise been due under this Employment Agreement.
F5: On December 19, 2025, the Convertible Promissory Note was paid in full.
F6: Represents the maturity date of the Convertible Promissory Note.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · nonDerivative · entry 5 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,305,000 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3 · ownership.direct: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. Read SEC document |
| August 11, 2026 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · nonDerivative · entry 4 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| July 28, 2026 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 2,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · nonDerivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 F4 · price: Issuable to Mr. Cohen as a bonus in lieu of a change of control payment which would have otherwise been due under this Employment Agreement. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantStock Option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 8 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2035-09-09 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F5 · derivative.exercise_date: The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | Disposition to issuerStock Option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 7 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000,000 shares Expires 2035-09-09 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F5 · derivative.exercise_date: The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantStock Option (right to buy) · Derivative | 83,333 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 6 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,333 Underlying: Common Stock · 83,333 shares Expires 2028-12-28 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | Disposition to issuerStock Option (right to buy) · Derivative | 83,333 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 5 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 83,333 shares Expires 2028-12-28 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.45 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 4 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-09-01 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F4 · derivative.exercise_date: A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| March 16, 2026 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | Disposition to issuerStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0001493152-26-011914 · ownership.xml · derivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2027-09-01 F3 · kind: On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable. F4 · derivative.exercise_date: A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025. F1 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| December 19, 2025 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | OtherConvertible Promissory Note · Derivative | Not disclosed | $0.00 Strike: $1.79 | $100,000.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · derivative · entry 6 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 56,023 shares Expires 2026-05-02 F5 · kind: On December 19, 2025, the Convertible Promissory Note was paid in full. F6 · derivative.expiration_date: Represents the maturity date of the Convertible Promissory Note. F3 · ownership.direct: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2025 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,305,000 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3 · ownership.direct: Securities held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. Read SEC document |
| September 30, 2025 Filed Oct 6, 2026 12:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-045858 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| September 09, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantStock Option (right to buy) · Derivative | 2,000,000 | $0.00 Strike: $2.30 | $0.00 |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · derivative · entry 6 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,000,000 Underlying: Common Stock · 2,000,000 shares Expires 2035-09-09 F4 · kind: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F7 · derivative.exercise_date: The options vest over 18 months with 500,000 of the options vesting upon grant and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| September 09, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 500,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · nonDerivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 F4 · kind: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer during 2025. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · price: Represents Mr. Cohen's direct ownership of the Issuer. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| July 21, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantWarrant to Purchase Common Stock · Derivative | 50,000 | Not disclosed Strike: $1.85 | Not disclosed |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · derivative · entry 5 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-07-21 F5 · kind: On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. F5 · price: On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. Read SEC document |
| July 21, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantConvertible Promissory Note · Derivative | Not disclosed | Not disclosed Strike: $1.79 | $100,000.00 |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · derivative · entry 4 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: Not disclosed Underlying: Common Stock · 56,023 shares Expires 2026-05-02 F5 · kind: On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. F5 · price: On July 21, 2025, the Company entered into an Agreement to Amend Promissory Note, with Tiger Cub, pursuant to which Tiger Cub and the Company agreed to amend and restate a prior $100,000 Promissory Note into an Amended and Restated Convertible Promissory Note (the "A&R Note"); and the Company granted Tiger Cub warrants to purchase 50,000 shares of common stock. The A&R Note, among other things, amended and restated the Promissory Note to provide Tiger Cub the option to convert the principal and accrued interest under the note into shares of common stock of the Company at a conversion price of $1.785 per share. The Note accrues interest at 18% per annum and the number of shares shown in the table above does not include interest which is also convertible into common stock of the Company. F6 · derivative.expiration_date: Represents the maturity date of the Convertible Promissory Note. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. Read SEC document |
| June 05, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 805,000 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F1 · price: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee ("Tiger Cub"). Mr. Cohen disclaims beneficial ownership of the securities held by Tiger Cub except to the extent of his pecuniary interest therein. Read SEC document |
| June 05, 2025 Filed Mar 20, 2026 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-011921 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F1 · price: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| April 10, 2025 Filed Apr 11, 2025 17:00 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-003873 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| April 10, 2025 Filed Sep 30, 2025 16:59 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-016352 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 F1 · kind: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F1 · price: Issued as a discretionary bonus in consideration for services rendered as Chief Executive Officer of the Issuer. Issued under the registrant's Second Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 19:41 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-034060 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,075,000 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein. Read SEC document |
| August 26, 2024 Filed Aug 27, 2024 19:41 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-034060 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Represents the transfer of shares from Mr. Jacob D. Cohen to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2 · ownership.direct: Represents Mr. Cohen's direct ownership of the Issuer. Read SEC document |
| June 03, 2024 Filed Jun 5, 2024 17:15 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantCommon Stock | 800,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-022803 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 800,000 F2 · price: Issued as a bonus for fiscal 2024 for compensation as an officer of the Company. Granted under the Registrant's Amended and Restated 2022 Equity Incentive Plan. Exempt pursuant to Rule 16b-3. F3 · ownership.direct: Held directly by Mr. Cohen. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:52 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GrantStock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $0.32 | $0.00 |
DisclosureSEC source: 0001493152-23-046643 · ownership.xml · derivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250,000 Underlying: Common Stock · 1,250,000 shares Expires 2028-12-28 F2 · kind: Granted in consideration for services rendered as an officer of the Registrant. Granted under the Registrant's 2022 Equity Incentive Plan. F3 · ownership.direct: Held directly by Mr. Cohen. Read SEC document |
| April 10, 2023 Filed May 2, 2023 20:50 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | PurchaseCommon Stock | 275,000 | $1.00 | $275,000.00 |
DisclosureSEC source: 0001493152-23-015227 · ownership.xml · nonDerivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,275,000 F4 · kind: Shares acquired in a private transaction. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Read SEC document |
| April 04, 2023 Filed May 2, 2023 20:50 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 8,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-015227 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000,000 F1 · kind: Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F3 · ownership.direct: Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Read SEC document |
| April 04, 2023 Filed May 2, 2023 20:50 UTC | MANGOCEUTICALS, INC. MGRX · Entity 8073 | GiftCommon Stock | 8,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-015227 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner Tiger Cub Trust · CIK 0001974475 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 F1 · kind: Represents the transfer of shares from Cohen Enterprises, Inc. which entity Mr. Jacob D. Cohen beneficially owns, to that of a trust which Mr. Cohen controls, The Tiger Cub Trust, which did not result in a change of beneficial ownership of such securities. F2 · ownership.nature: The shares are held in the name of Cohen Enterprises, Inc, which entity Mr. Cohen controls and which shares he is deemed to beneficially own. Read SEC document |
| February 15, 2023 Filed Apr 13, 2023 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | OtherSeries A Preferred Stock · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-012179 · ownership.xml · derivative · entry 4 Cohen Jacob D. · CIK 0001432078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F7 · kind: On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the "Exchange Agreement"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000. F4 · shares: Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer. F7 · price: On February 15, 2023, the Issuer and Jacob D. Cohen, entered into an Exchange Agreement (the "Exchange Agreement"), pursuant to which Mr. Cohen exchanged all 1,000,000 shares of the Series A Preferred Stock of the Issuer which he held with the Issuer for (a) all of the issued and outstanding membership interests held by the Issuer in Epiq Scripts, LLC; (b) all cash payments paid to the Issuer in the future as a Royalty Payment (as defined in the Royalty Agreement (defined below)) pursuant to that certain Royalty Agreement dated June 30, 2022, by and between Epiq MD, Inc. and the Issuer; (c) all proceeds that the Issuer receives from any sale of the equity of ZipDoctor, Inc.; and (d) the rights to all debt owed to the Issuer from Epiq Scripts, in the amount of approximately $850,000. F5 · derivative.expiration_date: The Series A Preferred Stock has no expiration date. F3 · derivative.underlying_shares: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F6 · derivative.underlying_shares: No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer. Read SEC document |
| December 31, 2022 Filed Apr 13, 2023 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | GrantCommon Stock | 6,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-012179 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 6,458,333 F1 · price: Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3. Read SEC document |
| May 06, 2022 Filed Apr 13, 2023 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | OtherSeries A Preferred Stock · Derivative | 1,000,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-23-012179 · ownership.xml · derivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · Not disclosed shares Expires not disclosed F3 · derivative.exercise_price: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F2 · kind: On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the "Restated Designation"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security. F4 · shares: Represents 100% of the outstanding shares of Series A Preferred Stock of the Issuer. F2 · price: On May 6, 2022, the Issuer filed a Second Amended and Restated Certificate of Designations of its Series A Convertible Preferred Stock (the "Restated Designation"). Upon the filing and effectiveness of the Restated Designation with the Secretary of State of the State of Nevada, each outstanding share of Series A Preferred Stock of the Company was automatically split, reclassified and converted into 1,000,000 shares of Series A Preferred Stock having the rights and privileges described in the Restated Designation. The Series A Preferred Stock (a) was also subject to a 1,000,000-for-1 forward stock split; and (b) amended to have a conversion right, changing such preferred stock from a non-derivative security, to a derivative security. F5 · derivative.expiration_date: The Series A Preferred Stock has no expiration date. F3 · derivative.underlying_shares: The Series A Preferred Stock may be converted into a number of shares of common stock of the Issuer equal to the holder's pro rata share of all Series A Preferred Stock then issued and outstanding, multiplied by (i) 60%, minus the aggregate percentage of the Issuer's outstanding common stock previously converted by holders of the Series A Preferred Stock, through such applicable date (currently zero), multiplied by (ii) the outstanding shares of Issuer common immediately after such conversion, divided by (iii) the total number of shares of Series A Preferred Stock then outstanding. F6 · derivative.underlying_shares: No individual conversion by any individual holder of Series A Preferred Stock may be in an amount greater than 9.99% of the outstanding common stock of the Issuer on the date on which the holder delivers notice of such conversion to the Issuer. Read SEC document |
| May 06, 2022 Filed Apr 13, 2023 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | OtherSeries A Preferred Stock | 1 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-012179 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Issued as a one-time bonus for services as an officer of the Company. Full vested upon issuance. Exempt under Rule 16b-3. Read SEC document |
| January 12, 2022 Filed Jan 20, 2022 16:00 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | GrantCommon Stock | 5,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-001719 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 27,500,000 F1 · kind: Issued in consideration for entering into Executive Employment Agreement of even date with issuance. Exempt under Rule 16b-3(d). Read SEC document |
| January 22, 2021 Filed Apr 5, 2021 06:15 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | GrantCommon Stock | 2,500,000 | $0.38 | $950,000.00 |
DisclosureSEC source: 0001493152-21-007920 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 22,500,000 F1 · kind: Issued in consideration for services rendered as Chief Executive Officer. Exempt under Rule 16b-3(d). Read SEC document |
| October 02, 2020 Filed Nov 18, 2020 12:30 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | PurchaseCommon Stock | 4,000,000 | $0.00 | $1,200.00 |
DisclosureSEC source: 0001493152-20-021911 · ownership.xml · nonDerivative · entry 3 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 20,000,000 F1 · price: Actual price paid for the shares were $0.00025 per share. The price reflected has been rounded up to the nearest decimal point. Read SEC document |
| October 02, 2020 Filed Nov 18, 2020 12:30 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | PurchaseCommon Stock | 7,000,000 | $0.00 | $1,400.00 |
DisclosureSEC source: 0001493152-20-021911 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 16,000,000 Read SEC document |
| May 22, 2020 Filed Jun 10, 2020 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | GrantCommon Stock | 3,000,000 | $0.26 | $780,000.00 |
DisclosureSEC source: 0001493152-20-010949 · ownership.xml · nonDerivative · entry 2 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Cohen Enterprises, Inc Disclosed balance after: 9,000,000 F3 · kind: Issued in consideration for services rendered as Chief Executive Officer. Exempt under Rule 16b-3(d). Read SEC document |
| May 20, 2020 Filed Jun 10, 2020 17:29 UTC | AMERICAN INTERNATIONAL HOLDINGS CORP. AMIH · Entity 114347 | GrantSeries A Preferred Stock | 1 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001493152-20-010949 · ownership.xml · nonDerivative · entry 1 Cohen Jacob D. · CIK 0001432078 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1 F1 · kind: Issued in consideration for services rendered as a member of the Board of Directors of the Issuer. Exempt under Rule 16b-3(d). There is no market for the share of Series A Preferred Stock, which share of Series A Preferred Stock, together with the other two outstanding shares of Series A Preferred Stock of the Issuer vote in aggregate sixty percent (60%) of the total vote on all shareholder matters, voting separately as a class. F1 · price: Issued in consideration for services rendered as a member of the Board of Directors of the Issuer. Exempt under Rule 16b-3(d). There is no market for the share of Series A Preferred Stock, which share of Series A Preferred Stock, together with the other two outstanding shares of Series A Preferred Stock of the Issuer vote in aggregate sixty percent (60%) of the total vote on all shareholder matters, voting separately as a class. F2 · balance_after: The Series A Preferred Stock is described in greater detail in the Current Report on Form 8-K filed by the Issuer with the Securities and Exchange Commission on May 21, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.